Abstract
Objective
Asthma is a chronic pulmonary inflammatory disease. MicroRNA (miR)-629-3p expression is reported to be up-regulated in the sputum of asthma patients. Nonetheless, miR-629-3p’s role and mechanism in asthma remain largely unknown. This study is aimed at exploring miR-629-3p’s role in regulating the injury and inflammation of bronchial epithelial cells.
Methods
Quantitative real-time polymerase chain reaction (qRT-PCR) was conducted to detect the expression levels of miR-629-3p and forkhead box a2 (FOXA2) mRNA in 16HBE cells treated with interleukin-13 (IL-13). 16HBE cell viability was evaluated using the cell counting kit-8 (CCK-8) assay, and cell apoptosis was analyzed by a flow cytometer. The levels of C-C motif chemokine ligand 11 (CCL11), C-C motif chemokine ligand 26 (CCL26), C-C motif ligand 2 (CCL-2)/mono-cyte chemotactic protein-1 (MCP-1), interleukin-1 beta (IL-1b), and interleukin 6 (IL-6) in 16HBE cell supernatant were detected through enzyme-linked immunosorbent assay (ELISA). The downstream target genes of miR-629-3p were predicted through bioinformatics. Besides, the targeted relationship between miR-629-3p and FOXA2 mRNA 3′-UTR was verified by dual-luciferase reporter gene assay. Western blot was utilized to determine the regulatory effects of miR-629-3p on the expression of FOXA2 protein in 16HBE cells.
Results
MiR-629-3p expression was significantly enhanced in IL-13-stimulated 16HBE cells while the FOXA2 mRNA and protein levels were significantly down-regulated. The transfection of miR-629-3p mimics inhibited 16HBE cells’ viability, and promoted the apoptosis and the secretion of chemokines CCL11, CCL26, CCL-2/MCP-1, IL-1b, and IL-6 of 16HBE cells, whereas inhibiting miR-629-3p had the opposite effects. Moreover, FOXA2 was identified as a downstream miR-629-3p target, and its overexpression reversed the effects of the miR-629-3p on 16HBE cells.
Conclusion
MiR-629-3p promotes IL-13-induced 16HBE cells’ injury and inflammation by targeting FOXA2.
Similar content being viewed by others
References
Athari, S. S. (2019). Targeting cell signaling in allergic asthma. Signal Transductuction and Targeted Therapy, 4, 45.
Li, J., Zheng, M., Wang, C., Jiang, J., Xu, C., Li, L., Li, L., Yan, G. & Jin, Y. (2020). Cryptotanshinone attenuates allergic airway inflammation through negative regulation of NF-κB and p38 MAPK. Bioscience, Biotechnology, and Biochemistry, 84(2), 268–278.
Boulet, L. P.(2018). Airway remodeling in asthma: update on mechanisms and therapeutic approaches. Current Opinion in Pulmonary Medicine, 24(1), 56–62.
Gon, Y., & Hashimoto, S. (2018). Role of airway epithelial barrier dysfunction in pathogenesis of asthma. Allergology International, 67(1), 12–17.
Bok, S. H., Seo, J. H., Bae, C. S., Kang, B., Cho, S. S., & Park, D. H. (2019). Allium hookeri root extract regulates asthmatic changes through immunological modulation of Th1/Th2‑related factors in an ovalbumin‑induced asthma mouse model. Molecular Medicine Reports, 20(4), 3215–3223.
McCracken, J. L., Veeranki, S. P., Ameredes, B. T., & Calhoun, W. J. (2017). Diagnosis and management of asthma in adults: a review. JAMA., 318(3), 279–290.
Pan, J., Yang, Q., Zhou, Y., Deng, H., Zhu, Y., Zhao, D. & & Liu, F. (2020). MicroRNA-221 modulates airway remodeling via the PI3K/AKT pathway in OVA-induced chronic murine asthma. Frontiers in Cell and Developmental Biology, 8, 495 Jun 30.
Alharris, E., Alghetaa, H., Seth, R., Chatterjee, S., Singh, N. P., Nagarkatti, M., & Nagarkatti, P. (2018). Resveratrol attenuates allergic asthma and associated inflammation in the lungs through regulation of miRNA-34a that targets FoxP3 in mice. Frontiers in Immunology, 9, 2992.
Lou, L., Tian, M., Chang, J., Li, F., & Zhang, G. (2020). MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7. Biomedicine & Pharmacotherapy, 122, 109692.
Lou, L., Tian, M., Chang, J., Li, F., & Zhang, G. (2020). MiRNA-192-5p attenuates airway remodeling and autophagy in asthma by targeting MMP-16 and ATG7. Biomedicine & Pharmacotherapy, 122, 109692.
Li, B. B., Chen, Y. L., & Pang, F. (2020). MicroRNA-30a targets ATG5 and attenuates airway fibrosis in asthma by suppressing autophagy. Inflammation, 43(1), 44–53.
Maes, T., Cobos, F. A., Schleich, F., Sorbello, V., Henket, M., De Preter, K., Bracke, K. R., Conickx, G., Mesnil, C., Vandesompele, J., Lahousse, L., Bureau, F., Mestdagh, P., Joos, G. F., Ricciardolo, F. L., Brusselle, G. G., & Louis, R. (2016). Asthma inflammatory phenotypes show differential microRNA expression in sputum. Journal of Allergy and Clinical Immunology, 137(5), 1433–1446.
Aghaei, M., Khodadadian, A., Elham, K. N., Nazari, M., & Babakhanzadeh, E. (2020). Major miRNA involved in insulin secretion and production in beta-cells. International Journal of General Medicine, 13, 89–97.
Wei, C., Tang, X., Wang, F., Li, Y., Sun, L., & Luo, F. (2019). Molecular characterization of pulmonary defenses against bacterial invasion in allergic asthma: The role of Foxa2 in regulation of β-defensin 1. PLoS One, 14(12), e0226517.
Zhang, K., Liang, Y., Feng, Y., Wu, W., Zhang, H., He, J., Hu, Q., Zhao, J., Xu, Y., Liu, Z. & & Zhen, G. (2018). Decreased epithelial and sputum miR-221-3p associates with airway eosinophilic inflammation and CXCL17 expression in asthma. American Journal of Physiology-Lung Cellular and Molecular Physiology, 315(2), L253–L264.
Li, B., Meng, Y. Q., Li, Z., Yin, C., Lin, J. P., Zhu, D. J., & Zhang, S. B. (2019). MiR-629-3p-induced downregulation of SFTPC promotes cell proliferation and predicts poor survival in lung adenocarcinoma. Artificial Cells, Nanomedicine, and Biotechnology, 47(1), 3286–3296.
Makita, K., Mikami, Y., Matsuzaki, H., Miyashita, N., Takeshima, H., Noguchi, S., Horie, M., Urushiyama, H., Iikura, M., Hojo, M., Nagase, T. & Yamauchi, Y. (2018). Mechanism of periostin production in human bronchial smooth muscle cells. International Archives of Allergy and Immunology, 175(1-2), 26–35.
Río-Araiza, V. H. D., Nava-Castro, K. E., Alba-Hurtado, F., Quintanar-Stephano, A., Aguilar-Díaz, H., Muñoz-Guzmán, M. A., Ostoa-Saloma, P., Ponce-Regalado, M. D., & Morales-Montor, J. (2018). Prolactin as immune cell regulator in Toxocara canis somatic larvae chronic infection. Bioscience Reports, 38(4), BSR20180305.
Busse, W. W. (2019). Biological treatments for severe asthma: A major advance in asthma care. Allergology International, 68(2), 158–166.
Crapster-Pregont, M., Yeo, J., Sanchez, R. L., & Kuperman, D. A. (2012). Dendritic cells and alveolar macrophages mediate IL-13-induced airway inflammation and chemokine production. Journal of Allergy and Clinical Immunology, 129(6), 1621–1627.
Matsukura, S., Osakabe, Y., Sekiguchi, A., Inoue, D., Kakiuchi, Y., Funaki, T., Yamazaki, Y., Takayasu, H., Tateno, H., Kato, E., Wakabayashi, A., Hayashi, M., Ishii, G., Yamaguchi, F., Tsuchiya, Y., Kasahara, K., Sagara, H., & Kokubu, F. (2016). Overexpression of microRNA-155 suppresses chemokine expression induced by Interleukin-13 in BEAS-2B human bronchial epithelial cells. Allergology International, 65(Suppl), S17–S23.
Ntontsi, P., Papathanassiou, E., Loukides, S., Bakakos, P., & Hillas, G. (2018). Targeted anti-IL-13 therapies in asthma: current data and future perspectives. Expert Opinion on Investigational Drugs, 27(2), 179–186.
Chen, J., Li, C., Liu, W., Yan, B., Hu, X., & Yang, F. (2019). miRNA-155 silencing reduces sciatic nerve injury in diabetic peripheral neuropathy. Journal of Molecular Endocrinology, 63(3), 227–238.
Jin, A., Bao, R., Roth, M., Liu, L., Yang, X., Tang, X., Yang, X., Sun, Q., & Lu, S. (2019). microRNA-23a contributes to asthma by targeting BCL2 in airway epithelial cells and CXCL12 in fibroblasts. Journal of Cellular Physiology, 234(11), 21153–21165.
Bartel, S., La Grutta, S., Cilluffo, G., Perconti, G., Bongiovanni, A., Giallongo, A., Behrends, J., Kruppa, J., Hermann, S., Chiang, D., Pfaffl, M. W., & Krauss-Etschmann, S. (2020). Human airway epithelial extracellular vesicle miRNA signature is altered upon asthma development. Allergy., 75(2), 346–356.
Xiong, T., Du, Y., Fu, Z. & Geng, G. (2019). MicroRNA-145-5p promotes asthma pathogenesis by inhibiting kinesin family member 3A expression in mouse airway epithelial cells. Journal of International Medical Research, 47(7), 3307–3319.
Zhang, H., Sun, Y., Rong, W., Fan, L., Cai, Y., Qu, Q., Gao, Y. & Zhao, H. (2018). miR-221 participates in the airway epithelial cells injury in asthma via targeting SIRT1. Experimental Lung Research, 44(6), 272–279.
Huo, X., Zhang, K., Yi, L., Mo, Y., Liang, Y., Zhao, J., Zhang, Z., Xu, Y., & Zhen, G. (2016). Decreased epithelial and plasma miR-181b-5p expression associates with airway eosinophilic inflammation in asthma. Clinical & Experimental Allergy, 46(10), 1281–1290.
Li, B., Meng, Y. Q., Li, Z., Yin, C., Lin, J. P., Zhu, D. J., & Zhang, S. B. (2019). MiR-629-3p-induced downregulation of SFTPC promotes cell proliferation and predicts poor survival in lung adenocarcinoma. Artificial Cells, Nanomedicine, and Biotechnology, 47(1), 3286–3296.
Maier, J. A., Lo, Y., & Harfe, B. D. (2013). Foxa1 and Foxa2 are required for formation of the intervertebral discs. PLoS One, 8(1), e55528.
Li, X., Liu, H., Lv, Y., Yu, W., Liu, X., & Liu, C. (2020). MiR-130a-5p/Foxa2 axis modulates fetal lung development in congenital diaphragmatic hernia by activating the Shh/Gli1 signaling pathway. Life Sciences, 241, 117166.
Mei, M., Nie, J., Sun, H., Wang, H. & Rong, L. (2020). LncRNA-NEF regulated the hyperoxia-induced injury of lung epithelial cells by FOXA2. American Journal of Translational Research, 12(9), 5563–5574.
Kistemaker, L. E., Hiemstra, P. S., Bos, I. S., Bouwman, S., van den Berge, M., Hylkema, M. N., Meurs, H., Kerstjens, H. A., & Gosens, R. (2015). Tiotropium attenuates IL-13-induced goblet cell metaplasia of human airway epithelial cells. Thorax, 70(7), 668–676.
Choi, W., Choe, S., & Lau, G. W. (2020). Inactivation of FOXA2 by respiratory bacterial pathogens and dysregulation of pulmonary mucus homeostasis. Frontiers in Immunology, 11, 515.
Salem, M., O’Brien, J. A., Bernaudo, S., Shawer, H., Ye, G., Brkić, J., Amleh, A., Vanderhyden, B. C., Refky, B., Yang, B. B., Krylov, S. N., & Peng, C. (2018). miR-590-3p promotes ovarian cancer growth and metastasis via a novel FOXA2-versican pathway. Cancer Research, 78(15), 4175–4190.
Zhang, J., Zhang, Z., Sun, J., Ma, Q., Zhao, W., Chen, X., & Qiao, H. (2019). MiR-942 regulates the function of breast cancer cell by targeting FOXA2. Bioscience Reports, 39(11), BSR20192298.
Liu, J. H., Li, C., Zhang, C. H., & Zhang, Z. H. (2020). LncRNA-CASC7 enhances corticosteroid sensitivity via inhibiting the PI3K/AKT signaling pathway by targeting miR-21 in severe asthma. Pulmonology, 26(1), 18–26.
Yang, W., Chen, Y., Huang, C., Wang, W., Huang, C., & Li, Y. (2021). MiR-18a inhibits PI3K/AKT signaling pathway to regulate PDGF BB-induced airway smooth muscle cell proliferation and phenotypic transformation. Physiological Research, 70(6), 883.
Cao, J., Wang, X., Wang, D., Ma, R., Li, X., Feng, H., Wang, J., Liu, S., & Wang, L. (2019). PGC-1β cooperating with FOXA2 inhibits proliferation and migration of breast cancer cells. Cancer Cell International, 19, 93.
Acknowledgements
We thank Hubei Yican Health Industry Co., Ltd (Wuhan, China) for its linguistic assistance during the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors declare no competing interests.
Ethical Approval
Our study was approved by the Ethics Review Board of YJinxiang People’s Hospital.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Jian, G., Yangli, J., Chao, Z. et al. MicroRNA-629-3p Promotes Interleukin-13-Induced Bronchial Epithelial Cell Injury and Inflammation by Targeting FOXA2. Cell Biochem Biophys 80, 457–466 (2022). https://doi.org/10.1007/s12013-022-01072-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12013-022-01072-6